“…A third message comes from the observed trend between the neutralization titres at 6 months and the number of symptoms reported, but not the duration of symptoms. Patients in this cohorts reported a median of 5 symptoms (interquartile range -IQR: 4À8), with the most common being fatigue (73%), fever (71%), and headache (67%), elapsing a median of 14 days (IQR: 8À16) [1].…”